Professor Per-Ola Carlsson, of Uppsala University and Uppsala University Hospital, has been awarded the 2026 Kerstin Brismar Award, which includes a research grant of SEK 500,000.
Per-Ola Carlsson receives the award for his “groundbreaking, world-leading translational research into type 1 diabetes”.
He led the world’s first study to evaluate the survival of genetically modified insulin-producing cells transplanted without immunosuppressive treatment. The study showed that the transplanted cells survived and continued to function for almost a year.